World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
106
Citations
39514
World Ranking
6563
National Ranking
3486

James L.M. Ferrara publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where James L.M. Ferrara sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 404 publications — 39th percentile

39% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

James L.M. Ferrara D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where James L.M. Ferrara sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 106 D-Index — 69th percentile

69% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

James L.M. Ferrara is affiliated with the Icahn School of Medicine at Mount Sinai in the United States. Their research primarily focuses on medicine, with a significant emphasis on hematology, immunology, genetics, public health, and pediatrics. They have contributed extensively to the study of hematopoietic stem cell transplantation and related topics.

Ferrara's work covers several key areas:

  • Hematopoietic Stem Cell Transplantation
  • Acute Lymphoblastic Leukemia research
  • Childhood Cancer Survivors' Quality of Life
  • Immune Cell Function and Interaction
  • Mesenchymal stem cell research
  • Pancreatic and Hepatic Oncology Research
  • IL-33, ST2, and ILC Pathways

The scientist has published research in multiple venues, with frequent publications in:

  • Transplantation and Cellular Therapy
  • Blood
  • Blood Advances
  • Science Translational Medicine
  • Gastroenterology

Notable recent papers include:

  • "Phase II Trial of Costimulation Blockade With Abatacept for Prevention of Acute GVHD" (2021), Journal of Clinical Oncology
  • "Obesity induces gut microbiota alterations and augments acute graft-versus-host disease after allogeneic stem cell transplantation" (2020), Science Translational Medicine
  • "Effective treatment of low-risk acute GVHD with itacitinib monotherapy" (2022), Blood
  • "Incidence, clinical presentation, risk factors, outcomes, and biomarkers in de novo late acute GVHD" (2023), Blood Advances
  • "Biomarker-guided preemption of steroid-refractory graft-versus-host disease with α-1-antitrypsin" (2020), Blood Advances

Frequent collaborators in their research include:

  • John E. Levine
  • Aaron Etra
  • Hannah Choe
  • William J. Hogan
  • Elizabeth O. Hexner

Best Publications

  • Graft-versus-host disease

    James L M Ferrara;John E Levine;Pavan Reddy;Ernst Holler

  • Graft-versus-host disease

    J. L. M. Ferrara;H. J. Deeg

  • An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation : I. The roles of minor H antigens and endotoxin

    Kenneth R. Cooke;Lester Kobzik;Thomas R. Martin;Joanne Brewer

  • Total body irradiation and acute graft-versus-host disease: The role of gastrointestinal damage and inflammatory cytokines

    Geoffrey R. Hill;Geoffrey R. Hill;James M. Crawford;James M. Crawford;Kenneth R. Cooke;Kenneth R. Cooke;Yani S. Brinson;Yani S. Brinson

  • The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation

    Geoffrey R. Hill;James L. M. Ferrara

  • Pretreatment of Donor Mice With Granulocyte Colony-Stimulating Factor Polarizes Donor T Lymphocytes Toward Type-2 Cytokine Production and Reduces Severity of Experimental Graft-Versus-Host Disease

    Luying Pan;John Delmonte;Candice K. Jalonen;James L.M. Ferrara

  • Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia.

    David L. Porter;Mark S. Roth;Carol McGarigle;James Ferrara

  • International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium.

    Andrew C. Harris;Andrew C. Harris;Rachel Young;Rachel Young;Steven Devine;William J. Hogan

  • Acute graft-versus-host disease does not require alloantigen expression on host epithelium

    Takanori Teshima;Rainer Ordemann;Pavan Reddy;Svetlana Gagin

  • Metagenomic Analysis of the Stool Microbiome in Patients Receiving Allogeneic Stem Cell Transplantation: Loss of Diversity Is Associated with Use of Systemic Antibiotics and More Pronounced in Gastrointestinal Graft-versus-Host Disease

    Ernst Holler;Peter Butzhammer;Karin Schmid;Christian Hundsrucker

  • Blood and Marrow Transplant Clinical Trials Network Toxicity Committee consensus summary: Thrombotic microangiopathy after hematopoietic stem cell transplantation

    Vincent T. Ho;Corey Cutler;Shelly Carter;Paul Martin

  • Pathophysiologic mechanisms of acute graft-vs.-host disease

    James L.M. Ferrara;Robert Levy;Nelson J. Chao

  • A biomarker panel for acute graft-versus-host disease

    Sophie Paczesny;Sophie Paczesny;Oleg I Krijanovski;Thomas M Braun;Sung Won Choi

  • ST2 as a Marker for Risk of Therapy-Resistant Graft-versus-Host Disease and Death

    Mark T. Vander Lugt;Thomas M. Braun;Samir Hanash;Jerome Ritz

  • Recommended Screening and Preventive Practices for Long-term Survivors after Hematopoietic Cell Transplantation: Joint Recommendations of the European Group for Blood and Marrow Transplantation, the Center for International Blood and Marrow Transplant Research, and the American Society of Blood and Marrow Transplantation

    J. Douglas Rizzo;John R. Wingard;Andre Tichelli;Stephanie J. Lee

  • Tumor necrosis factor- alpha production to lipopolysaccharide stimulation by donor cells predicts the severity of experimental acute graft-versus-host disease.

    Kenneth R. Cooke;Geoffrey R. Hill;James M. Crawford;David Bungard

  • Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease

    James L.M. Ferrara;Andrew C. Harris;Joel K. Greenson;Thomas M. Braun

  • LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation.

    Kenneth R. Cooke;Armin Gerbitz;James M. Crawford;Takanori Teshima

  • Interleukin-11 promotes T cell polarization and prevents acute graft-versus-host disease after allogeneic bone marrow transplantation.

    Geoffrey R. Hill;Kenneth R. Cooke;Takanori Teshima;James M. Crawford

  • EBMT-NIH-CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment.

    Helene M. Schoemans;Stephanie J. Lee;James L. Ferrara;Daniel Wolff

Frequent Co-Authors

John E. Levine
John E. Levine Icahn School of Medicine at Mount Sinai
Pavan Reddy
Pavan Reddy Baylor College of Medicine
Kenneth R. Cooke
Kenneth R. Cooke Johns Hopkins University School of Medicine
Sophie Paczesny
Sophie Paczesny Medical University of South Carolina
Takanori Teshima
Takanori Teshima Hokkaido University
Chen Liu
Chen Liu Yale University
Ernst Holler
Ernst Holler University of Regensburg
Geoffrey R. Hill
Geoffrey R. Hill Fred Hutchinson Cancer Research Center
Daniel J. Weisdorf
Daniel J. Weisdorf University of Minnesota
Vincent T. Ho
Vincent T. Ho Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re exploring medicine in the USA, there are several flexible online degrees and alternative career pathways to consider. Many healthcare professionals today are seeking advanced roles without the traditional academic hurdles—online dnp programs without dissertation offer a streamlined route to a Doctor of Nursing Practice, letting you focus on clinical leadership instead of intensive research.

For those aiming to enter the field quickly, you might wonder what is the fastest way to become an lpn. Online fast-track LPN programs are designed for speed without sacrificing the quality of clinical training, helping you launch your healthcare career efficiently.

Mental health is a growing concern in the medical community. With fast track mental health nursing programs, registered nurses can specialize quickly as psychiatric-mental health nurse practitioners and meet urgent community needs.

Alternatively, if you’re interested in the administrative side of healthcare, best online mha programs provide an affordable and flexible way to gain leadership and organizational skills for managing health services.

Best Scientists Citing James L.M. Ferrara

Trending Scientists

Recently Published Articles